Public Release: 27-Aug-2018
‘Rosehip’ neurons not found in rodents, may be involved in fine-level control between regions of the human brain
IMAGE: This is a digital reconstruction of a rosehip neuron in the human brain.
Credit: Tamas Lab, University of Szeged
One of the most intriguing questions about the human brain is also one of the most difficult for neuroscientists to answer: What sets our brains apart from those of other animals?
“We really don’t understand what makes the human brain special,” said Ed Lein, Ph.D., Investigator at the Allen Institute for Brain Science. “Studying the differences at the level of cells and circuits is a good place to start, and now we have new tools to do just that.”
In a new study published today in the journal Nature Neuroscience, Lein and his colleagues reveal one possible answer to that difficult question. The research team, co-led by Lein and Gábor Tamás, Ph.D., a neuroscientist at the University of Szeged in Szeged, Hungary, has uncovered a new type of human brain cell that has never been seen in mice and other well-studied laboratory animals.
Tamás and University of Szeged doctoral student Eszter Boldog dubbed these new cells “rosehip neurons” — to them, the dense bundle each brain cell’s axon forms around the cell’s center looks just like a rose after it has shed its petals, he said. The newly discovered cells belong to a class of neurons known as inhibitory neurons, which put the brakes on the activity of other neurons in the brain.
The study hasn’t proven that this special brain cell is unique to humans. But the fact that the special neuron doesn’t exist in rodents is intriguing, adding these cells to a very short list of specialized neurons that may exist only in humans or only in primate brains.
The researchers don’t yet understand what these cells might be doing in the human brain, but their absence in the mouse points to how difficult it is to model human brain diseases in laboratory animals, Tamás said. One of his laboratory team’s immediate next steps is to look for rosehip neurons in postmortem brain samples from people with neuropsychiatric disorders to see if these specialized cells might be altered in human disease.
When different techniques converge
In their study, the researchers used tissue samples from postmortem brains of two men in their 50s who had died and donated their bodies to research. They took sections of the top layer of the cortex, the outermost region of the brain that is responsible for human consciousness and many other functions that we think of as unique to our species. It’s much larger, compared to our body size, than in other animals.
“It’s the most complex part of the brain, and generally accepted to be the most complex structure in nature,” Lein said.
Tamás’ research lab in Hungary studies the human brain using a classical approach to neuroscience, conducting detailed examinations of cells’ shapes and electrical properties. At the Allen Institute, Lein leads a team working to uncover the suite of genes that make human brain cells unique from each other and from the brain cells of mice.
Several years ago, Tamás visited the Allen Institute to present his latest research on specialized human brain cell types, and the two research groups quickly saw that they’d hit on the same cell using very different techniques.
“We realized that we were converging on the same cell type from absolutely different points of view,” Tamás said. So they decided to collaborate.
The Allen Institute group, in collaboration with researchers from the J. Craig Venter Institute, found that the rosehip cells turn on a unique set of genes, a genetic signature not seen in any of the mouse brain cell types they’ve studied. The University of Szeged researchers found that the rosehip neurons form synapses with another type of neuron in a different part of the human cortex, known as pyramidal neurons.
This is one of the first studies of the human cortex to combine these different techniques to study cell types, said Rebecca Hodge, Ph.D., Senior Scientist at the Allen Institute for Brain Science and an author on the study.
“Alone, these techniques are all powerful, but they give you an incomplete picture of what the cell might be doing,” Hodge said. “Together, they tell you complementary things about a cell that can potentially tell you how it functions in the brain.”
How do you study humanity?
What appears to be unique about rosehip neurons is that they only attach to one specific part of their cellular partner, indicating that they might be controlling information flow in a very specialized way.
If you think of all inhibitory neurons like brakes on a car, the rosehip neurons would let your car stop in very particular spots on your drive, Tamás said. They’d be like brakes that only work at the grocery store, for example, and not all cars (or animal brains) have them.
“This particular cell type — or car type — can stop at places other cell types cannot stop,” Tamás said. “The car or cell types participating in the traffic of a rodent brain cannot stop in these places.”
The researchers’ next step is to look for rosehip neurons in other parts of the brain, and to explore their potential role in brain disorders. Although scientists don’t yet know whether rosehip neurons are truly unique to humans, the fact that they don’t appear to exist in rodents is another strike against the laboratory mouse as a perfect model of human disease — especially for neurological diseases, the researchers said.
“Our brains are not just enlarged mouse brains,” said Trygve Bakken, M.D., Ph.D., Senior Scientist at the Allen Institute for Brain Science and an author on the study. “People have commented on this for many years, but this study gets at the issue from several angles.”
“Many of our organs can be reasonably modeled in an animal model,” Tamás said. “But what sets us apart from the rest of the animal kingdom is the capacity and the output of our brain. That makes us human. So it turns out humanity is very difficult to model in an animal system.”
Other co-authors on the study include Jennie Close, Song-Lin Ding, Jeremy Miller, Soraya Shehata, Kimberly Smith, Susan Sunkin and Abby Wall of the Allen Institute for Brain Science; Judith Baka, Sándor Bordé, Nóra Faragó, Ágnes K. Kocsis, Balázs Kovács, Gábor Molnár, Gáspár Oláh, Attila Ozsvár, Márton Rózsa and Pál Barzó of the University of Szeged; Mark Novotny, Brian Aevermann, Francisco Diez-Fuertes, Jamison McCorrison, Danny Tran, Pratap Venepally, Roger Lasken, Nicholas Schork and Richard Scheuermann of the J. Craig Venter Institute; László Puskás of the Hungarian Academy of Sciences; and Frank Steemers of Illumina, Inc.